These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25083893)

  • 1. Noninvasive prenatal testing by maternal plasma DNA analysis: current practice and future applications.
    Chiu RW
    Scand J Clin Lab Invest Suppl; 2014; 244():48-53; discussion 51-2. PubMed ID: 25083893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.
    Gray KJ; Wilkins-Haug LE
    Pediatr Radiol; 2018 Apr; 48(4):461-470. PubMed ID: 29550862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New frontiers in noninvasive, prenatal screening and diagnosis: fetal DNA circulating in maternal blood].
    Montagnana M; Lippi G; Guidi GC
    Minerva Ginecol; 2007 Jun; 59(3):331-41. PubMed ID: 17576408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art.
    Lo YM
    BJOG; 2009 Jan; 116(2):152-7. PubMed ID: 19076946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood.
    Sekizawa A; Purwosunu Y; Matsuoka R; Koide K; Okazaki S; Farina A; Saito H; Okai T
    J Obstet Gynaecol Res; 2007 Dec; 33(6):747-64. PubMed ID: 18001438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
    Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
    Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
    Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications of maternal plasma fetal DNA analysis: translating the fruits of 15 years of research.
    Chiu RW; Lo YM
    Clin Chem Lab Med; 2013 Jan; 51(1):197-204. PubMed ID: 23072857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age.
    Chiu RW; Lo YM
    Semin Fetal Neonatal Med; 2011 Apr; 16(2):88-93. PubMed ID: 21075065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antenatal noninvasive DNA testing: clinical experience and impact.
    Ferres MA; Hui L; Bianchi DW
    Am J Perinatol; 2014 Aug; 31(7):577-82. PubMed ID: 24683075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive prenatal diagnosis of Down syndrome: current knowledge and novel insights.
    Sifakis S; Papantoniou N; Kappou D; Antsaklis A
    J Perinat Med; 2012 Feb; 40(4):319-27. PubMed ID: 22752761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free fetal nucleic acid testing: a review of the technology and its applications.
    Sayres LC; Cho MK
    Obstet Gynecol Surv; 2011 Jul; 66(7):431-42. PubMed ID: 21944155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliable noninvasive prenatal testing by massively parallel sequencing of circulating cell-free DNA from maternal plasma processed up to 24h after venipuncture.
    Buysse K; Beulen L; Gomes I; Gilissen C; Keesmaat C; Janssen IM; Derks-Willemen JJ; de Ligt J; Feenstra I; Bekker MN; van Vugt JM; Geurts van Kessel A; Vissers LE; Faas BH
    Clin Biochem; 2013 Dec; 46(18):1783-6. PubMed ID: 23933476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies.
    Canick JA; Palomaki GE; Kloza EM; Lambert-Messerlian GM; Haddow JE
    Prenat Diagn; 2013 Jul; 33(7):667-74. PubMed ID: 23592541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan.
    Shaw SW; Chen CP; Cheng PJ
    Taiwan J Obstet Gynecol; 2013 Dec; 52(4):470-4. PubMed ID: 24411028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits and limitations of whole genome versus targeted approaches for noninvasive prenatal testing for fetal aneuploidies.
    Boon EM; Faas BH
    Prenat Diagn; 2013 Jun; 33(6):563-8. PubMed ID: 23613171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive prenatal detection of aneuploidy.
    Robinson C; van den Boom D; Bombard AT
    Clin Obstet Gynecol; 2014 Mar; 57(1):210-25. PubMed ID: 24351443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal assessment of fetal chromosomal and genetic disorders through maternal plasma DNA analysis.
    Liao GJ; Chiu RW; Lo YM
    Pathology; 2012 Feb; 44(2):69-72. PubMed ID: 22198255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.